Translation of "Comité ad hoc de révision de la génétique moléculaire " (French → English) :

There are two ways of resolving this problem: either reforming the COSS Regulation and granting COSS new powers, or setting up a new ad hoc committee competent to deal with protection of vessels, passengers and cargo, and likewise port installations, from the threat of criminal acts of an essentially terrorist nature, and which would also be responsible for adopting the implementing measures to which the present proposal for a regulation refers.

VI-Transboundary movement of genetically modified organisms PAGEREF _Toc13296716 \h VISOIL PROTECTION Council conclusions PAGEREF _Toc13296717 \h VIBIOLOGICAL DIVERSITY Council conclusions PAGEREF _Toc13296718 \h VIIIPACKAGING AND PACKAGING WASTE PAGEREF _Toc13296719 \h XIMAJOR ACCIDENTS INVOLVING DANGEROUS SUBSTANCES REVISION OF "SEVESO II" DIRECTIVE PAGEREF _Toc13296720 \h XIENVIRONMENTAL LIABILITY PAGEREF _Toc13296721 \h XISUSTAINABLE DEVELOPMENT STRATEGY REINFORCEMENT OF THE COUNCIL'S STRUCTURES PAGEREF _Toc13296722 \h XIISUSTAINABLE DEVELOPMENT PREPARATION OF THE JOHANNESBURG SUMMIT PAGEREF _Toc13296723 \h XIICLIMATE CHANGE - KYOTO PROTOCOL PAGEREF _Toc13296724 \h XIIICLIMATE CHANGE GREENHOUSE GAS EMISSION ALLOWANCE TRADING PAGEREF _To ...[+++]c13296725 \h XIIITRACEABILITY AND LABELLING OF GENETICALLY MODIFIED ORGANISMS PAGEREF _Toc13296726 \h XIVDANGEROUS CHEMICALS-Ratification of the Rotterdam Convention PAGEREF _Toc13296727 \h XIV-Trade in hazardous chemicals PAGEREF _Toc13296728 \h XIVOTHER BUSINESS-Clean technologies for diesel-engined cars PAGEREF _Toc13296729 \h XV-Chemicals policy PAGEREF _Toc13296730 \h XV-National sustainable development strategies PAGEREF _Toc13296731 \h XV-Production of ozone-depleting chlorofluorocarbons (CFCs) in the European Union PAGEREF _Toc13296732 \h XV-Coexistence of genetically modified, traditional and organic crops PAGEREF _Toc13296733 \h XV-Integrated product policy PAGEREF _Toc13296734 \h XV-Climate change Legislation on fluorinated gases PAGEREF _Toc13296735 \h XVIITEMS APPROVED WITHOUT DEBATEEXTERNAL RELATIONS--EU Liechtenstein relations Conclusions PAGEREF _Toc13296736 \h XVI--Afghanistan Appointment of the new Special Representative of the European Union PAGEREF _Toc13296737 \h XVI--FYROM Extension of the mandate of the Special Representative of the European Union PAGEREF _Toc13296738 \h XVI--Angola PAGEREF _Toc13296739 \h XVIIRELATIONS WITH ACP STATES--ACP-EC Council of Ministers (Punta Cana, 28 June 2002) PAGEREF _Toc13296 ...

Nevertheless, the Committee recommends that, if in future genetically modified plant products are considered for use in medical and hygiene cotton products, risk assessments should be carried out on a case-by-case basis to include: definition of the molecular inserts and their effect on metabolism and fibre structure, analysis of raw and processed fibres for protein content, evidence of the substantial equivalence of the physico-chemical characteristics of medical and hygiene products derived from either non-GM or GM plant material.

47. Endorses the Declarations made at the 24 June Environment Council by 11 Member States to suspend commercial releases of GMOs until revised safety regulations are implemented, but notes with dismay that under US pressure the Summit abandoned the concept of an independent international high council to take urgent action on the issues of human health and environmental well‑being arising from the commercial release of genetically modified organisms (GMOs) and relegated the matter to the relative obscurity of two OECD committees;

This programme continues, expands and supplements the work done under the molecular engineering programme, from which it follows on; it has a larger budget (55 million ECU at present, which will probably be increased after the upcoming programme review) and, in addition to the sectors already investigated covers such new fields of research as the study of protein architecture, the application of biotechnology to industrial microorganisms, in-vitro methods of analysing the pharmacological and toxicological properties of molecules and the determination of risks associated with genetic engineering.

This programme continues, expands and supplements the work done under the molecular engineering programme, from which it follows on; it has a larger budget (55 million ECU at present, which will probably be increased after the upcoming programme review) and, in addition to the sectors already investigated covers such new fields of research as the study of protein architecture, the application of biotechnology to industrial microorganisms, in-vitro methods of analysing the pharmacological and toxicological properties of molecules and the determination of risks associated with genetic engineering.